Literature DB >> 21846807

Immortalized mouse embryo fibroblasts are resistant to miR-290-induced senescence regardless of p53 status.

Milena Rizzo1, Monica Evangelista, Laura Mariani, Marcella Simili, Giuseppe Rainaldi, Letizia Pitto.   

Abstract

The prosenescence role of miR-290 and nocodazole has been documented in primary mouse embryo fibroblasts (MEF), while it is not clear whether immortal murine fibroblasts are still responsive to these senescence inducing stimuli. To establish this point, immortal murine fibroblasts with functional (NIH3T3) or nonfunctional p53 (I-MEF) and low levels of miR-290 were tested for their capability to undergo senescence after exposure to either nocodazole or miR-290. Our results clearly indicate that nocodazole induces senescence only in NIH3T3 cells with a functional p53 but not in I-MEF lacking a functional p53. miR-290 overexpression is unable to address any of the tested immortalized clones toward senescence, regardless of the p53 status, suggesting that the prosenescence role of miR-290 is specific for primary but not for immortal murine fibroblasts. Moreover our findings suggest that the mere downregulation of a potential tumor suppressor miRNA in a given cell type does not necessarily imply that it behaves as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846807     DOI: 10.1152/physiolgenomics.00064.2011

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  2 in total

1.  Effect of heat treatment on cytotoxicity of self-adhesive resin cements: Cell viability analysis.

Authors:  Celso Afonso Klein-Júnior; Roberto Zimmer; Guilherme Scotta Hentschke; Denise Cantarelli Machado; Rubem Beraldo Dos Santos; Eduardo Galia Reston
Journal:  Eur J Dent       Date:  2018 Apr-Jun

2.  miR290-5p/292-5p activate the immunoglobulin kappa locus in B cell development.

Authors:  Patty B Garcia; Amie Cai; Jamie G Bates; Hector Nolla; Mark S Schlissel
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.